Glucocorticoids interact with gp120 in causing neurotoxicity in striatal cultures

Brain Research

Volumn 808, Issue 2, 1998, Pages 305-309

  Iyer, Asha M ^a   Brooke, Sheila M ^a   Sapolsky, Robert M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

AIDS related dementia; Calcium; Glucocorticoid; gp120; HIV; Neuron death; Stress; Striatum

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; GLYCOPROTEIN GP 120; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEMENTIA; FETUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RAT;

AIDS DEMENTIA COMPLEX; ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCIUM; CELL DEATH; CELLS, CULTURED; CORPUS STRIATUM; CORTICOSTERONE; HIV ENVELOPE PROTEIN GP120; NEURONS; NEUROTOXINS; RATS; STRESS;

EID: 0032547870     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00819-1     Document Type: Article

References (26)

1. APA Taskforce on Laboratory Tests in Psychiatry Am. J. Psychiatry. 144:1987;1253-1266.
2. Barks J., Sun R.R, Malinak C., Silverstein F. gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rat. Exp. Neurol. 132:1995;123-133.
3. Bozzette S.A., Sattler F.R., Chiu J., Wu A.W., Gluckstein D., Kemper C., Bartok A., Niosi J., Abramson I., Coffman J. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. New Engl. J. Med. 323:1990;1451-1456.
4. Brenneman D.E., Westbrook G.L., Fitzgerald S.P., Ennist D.L., Elkins K.L., Ruff M.R., Pert C.B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (London). 335(6191):1988;639-642.
5. Brooke S., Chan R., Howard S., Sapolsky R. Endocrine modulation of the neurotoxicity of gp120: implications for aids-related dementia complex. PNAS. 94(17):1997;9457-9462.
6. S. Brooke, S. Howard, R. Sapolsky, Energy-Dependency of glucocorticoid exacerbation of gp120 neurotoxicity, J. Neurochem., in press.
7. Dobois- Dalcq M., Altmeyer R., Chiron M., Wilt S. HIV interactions with cells of the nervous system. Curr. Opin. Neurobiol. 5(5):1995;647-655.
8. Dreyer E., Kaiser P., Offermann J., Lipton S. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science. 248:1990;364-366.
9. el-Sadr W., Sidhu G., Diamond G. High-dose corticosteroids as adjunct therapy in severe Pneumocystis carinii pneumonia. AIDS Res. 2:1986;349-358.
10. Gagnon S., Boota A.M., Fischl M.A., Baier H., Kirksey O.W., La Voie L.S. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. New Engl. J. Med. 323:1990;1444-1447.
11. Gendelman H., Lipton S., Tardieu M., Bukrinsky M., Nottet H. The neuropathogenesis of HIV-1 infection. J. Leukocyte Biol. 56(3):1994;389-398.
12. Genis P., Jett M., Bernton E.W., Boyle T., Gelbard H.A., Dzenko K., Keane R.W., Resnick L., Mizrachi Y.et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176(6):1992;1703-1718.
13. Goodkin K., Wilkie F., Concha M., Asthana D., Shapshak P., Douyon R., Fujimura R., LoPiccolo C. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Neuroimaging Clin. North Am. 7:1997;561-579.
14. Kimes A., London E., Szabo G., Raymon L., Trabakoff B. Reduction of cerebral glucose utilization by the HIV envelope glycoprotein gp120. Exp. Neurol. 112(2):1991;224-228.
15. Lipton S. HIV-related neuronal injury. Mol. Neurobiol. 8(2-3):1994;181-196.
16. Masliah E., Ge N., Morey M., Deteresa R., Terry R., Wiley C. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest. 66(3):1992;285-291.
17. McEwen B. The brain is an important target of adrenal steroidactions. A comparison of synthetic and natural steroids. Ann. New York Acad. Sci. 823:1997;201-213.
18. Meyerhoff D., Weiner M., Fein G. Deep gray matter structures in HIV infection: A proton MR spectroscopic study. Am. J. Neuroradiol. 17:1996;973-978.
19. Raber J., Toggas S., Lee S., Bloom F., Epstein C., Mucke L. CNS Expression of HIV-1 Envelope Protein gp120 activates Hypothalamic-Pituitary-Adrenal(HPA) axis. Soc. Neurosci. Abstr. 22:1996;791.5.
20. Reagan L., McEwen B. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J. Chem. Neuroanat. 13:1997;149-167.
21. Rottenberg D., Sidtis J., Strother S., Schaper K.K, Anderson J., Nelson M., Price R. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J. Nucl. Med. 37:1996;1133-1141.
22. Sahakian B., Elliott R., Low N., Mehta M., Clark R., Pozniak A. Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men. Psychol. Med. 25:1995;1233-1246.
23. Sapolsky R. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress. 1:1996;1-19.
24. Sellmeyer D., Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr. Rev. 17:1996;518-533.
25. Toggas S., Masliah E., Rockenstein E., Rall G., Abraham C., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-190J.
26. Yanagisawa N. Historical review of research on functions of basal ganglia. Eur. Neurol. 36(1):1996;2-8.